HOME  |  CONTACT US  |  SUBSCRIBE  |  SUPPORT WLF

Publication Detail


Sixth Circuit Affirms Impossibility Preemption of Branded-Drug Design-Defect Claims
Topic: Federalism
By James M. Beck, Counsel in the Philadelphia, PA office of Reed Smith LLP.
Legal Opinion Letter, January 15, 2016, 2 pages
Download a PDF of the Publication
Related Publications:
Publication Summary:

A groundbreaking appellate court ruling could end state lawsuits that demand prescription drug makers redesign their products without prior FDA approval.
  • Welcome to the Washington Legal Foundation
  • 2009 Massachusetts Ave., NW
    Washington, DC 20036
  • info@wlf.org  |  ph. 202-588-0302
    ©2017 WLF All Rights Reserved